Puma Biotechnology Inc (PBYI) Social Stream



Puma Biotechnology Inc (PBYI): $2.00

0.01 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PBYI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Puma Biotechnology Inc (PBYI) Price Targets From Analysts

Use the tables below to see what analysts covering Puma Biotechnology Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-04 6 $15 $5 $8.6 $2.8 207.14%
2022-03-07 6 $15 $5 $8.4 $2.8 200%

The Trend in the Analyst Price Target


PBYI's average price target has moved down $1.93 over the prior 14 months.

Over the past 48 weeks, PBYI's average upside potential has been 46.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 9 15 6 9.57 10.71 -10.64%
2021-07-10 10 15 6 9.57 8.28 15.58%
2021-08-01 10 16 6 10.38 7.52 38.03%
2021-08-05 10 16 6 10.38 6.99 48.5%
2022-03-04 6 15 5 8.60 2.52 241.27%

PBYI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.83 2 0 2 1 1 6

The Trend in the Broker Recommendations


Over the past 25 months, PBYI's average broker recommendation rating improved by 0.61.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PBYI as an investment opportunity.

  • In the context of all US stocks, Puma Biotechnology Inc's variance in analysts' estimates is lower than -90.48% of them.
  • Puma Biotechnology Inc's average analyst price target is higher than 13.93% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Puma Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 182.07% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Puma Biotechnology Inc's number of analysts covering the stock is higher than 74.84% of them.

In the Pharmaceutical Products industry, PBH, PAHC, and ORGO are the three stocks most similar to Puma Biotechnology Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for PBYI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6149 seconds.